When psychedelics were first studied more than 50 years ago, researchers noticed that they were useful in helping people explore a greater sense of self. Now, after a half-century hiatus, scientists are studying psychedelics like MDMA, psilocybin, and ketamine as treatment for depression, PTSD, anxiety, and other mental health conditions. So, what promise do they hold as therapeutics? Albert Garcia-Romeu, a researcher at John’s Hopkins University, joins Dr. Sanjay Gupta to talk about how psychedelics can alleviate mental suffering and what the path forward might look like.
Anders Fogh Rasmussen on Putin and Ukraine
Anders Fogh Rasmussen, NATO’s secretary general from 2009-14, says the alliance should pledge to shoot down intruding Russian drones and fighter jets, while moving swiftly…
Thought Leader: Anders Fogh Rasmussen
Dr. Sanjay Gupta: Why Are So Many Young People Getting Cancer?
Cancer used to be something you worried about later in life — but not anymore. More and more young adults are being diagnosed, and doctors are…
Thought Leader: Sanjay Gupta
Josh Kraushaar: Hostage Deal and Ceasefire
Josh Kraushaar joined Hugh to discuss the deal for the release of the hostages and the ceasefire. Josh Kraushaar offers sharp, nonpartisan analysis grounded in…
Thought Leader: Josh Kraushaar
Dr. Sanjay Gupta: Beyond the Headlines of MAHA
Thought Leader: Sanjay Gupta
